ClinConnect ClinConnect Logo
Search / Trial NCT00001109

A Blood Test to Look at Cells of the Immune System in Healthy Children

Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Aug 30, 2001

Trial Information

Current as of March 19, 2025

Completed

Keywords

Monocytes Flow Cytometry Hiv Seronegativity Phenotype Lymphocyte Subsets

ClinConnect Summary

Early in life, the cells involved in immune selection differentiate into CD4+ and CD8+ cells. Currently there is insufficient information on the cell maturation and activation of these peripheral blood mononuclear cell (PBMC) subsets in normal children. The critical need for this information has been brought about by the pediatric HIV/AIDS epidemic, which requires the measurement of peripheral blood CD4+ T cells and other cells types for interpretation of HIV disease progression. The immunopathogenesis of pediatric HIV infection differs from that in adults but is not well understood. In ord...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • A child may be eligible for this study if he/she:
  • Is 0 - 18 years old.
  • Is HIV-negative and is born to an HIV-negative mother.
  • Is healthy (no serious infection or disease).
  • Has signed informed consent of a parent or legal guardian if under 18.
  • Exclusion Criteria
  • A child will not be eligible for this study if he/she:
  • Is pregnant or breast-feeding.
  • Has already completed this study once before.
  • Is taking prescription medications other than prescription vitamins.

Trial Officials

W Shearer

Study Chair

H Rosenblatt

Study Chair

About National Institute Of Allergy And Infectious Diseases (Niaid)

The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.

Locations

Los Angeles, California, United States

Springfield, Massachusetts, United States

Seattle, Washington, United States

Bronx, New York, United States

La Jolla, California, United States

Los Angeles, California, United States

Los Angeles, California, United States

San Francisco, California, United States

Washington, District Of Columbia, United States

Washington, District Of Columbia, United States

Miami, Florida, United States

Chicago, Illinois, United States

Chicago, Illinois, United States

Chicago, Illinois, United States

Baltimore, Maryland, United States

Boston, Massachusetts, United States

New Brunswick, New Jersey, United States

Newark, New Jersey, United States

Albany, New York, United States

Great Neck, New York, United States

New Hyde Park, New York, United States

New York, New York, United States

New York, New York, United States

Stony Brook, New York, United States

Durham, North Carolina, United States

Philadelphia, Pennsylvania, United States

Charleston, South Carolina, United States

Houston, Texas, United States

Bayamon, , Puerto Rico

San Juan, , Puerto Rico

San Juan, , Puerto Rico

Newark, New Jersey, United States

Bronx, New York, United States

New Orleans, Louisiana, United States

Worcester, Massachusetts, United States

Jacksonville, Florida, United States

Rochester, New York, United States

Birmingham, Alabama, United States

Mobile, Alabama, United States

Fort Lauderdale, Florida, United States

Riviera Beach, Florida, United States

Jackson, Mississippi, United States

Columbus, Georgia, United States

New Orleans, Louisiana, United States

Chicago, Illinois, United States

People applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials